SARTORIUS AG (SRT.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:SRT - DE0007165607 - Common Stock
SRT.DE Key Statistics, Chart & Performance
The current stock price of SRT.DE is 189.2 EUR. In the past month the price decreased by -1.77%. In the past year, price increased by 5.35%.
SRT.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| DIM.PA | SARTORIUS STEDIM BIOTECH | 46.98 | 19.71B | ||
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 45.14 | 18.94B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 53.33 | 18.21B | ||
| QIA.DE | QIAGEN N.V. | 20.39 | 9.06B | ||
| 1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 19.22 | 2.81B | ||
| EVT.DE | EVOTEC SE | N/A | 1.96B | ||
| GXI.DE | GERRESHEIMER AG | 6.74 | 858.66M | ||
| FF.MI | FINE FOODS & PHARMACEUTICALS | 10.61 | 208.25M |
Related stock screener links
About SRT.DE
Company Profile
Sartorius AG is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Goettingen, Niedersachsen and currently employs 13,878 full-time employees. Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. The company operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Company Info
SARTORIUS AG
Otto-Brenner-Str. 20
Goettingen NIEDERSACHSEN DE
Employees: 13573
Phone: 495513080
SARTORIUS AG / SRT.DE FAQ
What does SARTORIUS AG do?
Sartorius AG is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Goettingen, Niedersachsen and currently employs 13,878 full-time employees. Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. The company operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Can you provide the latest stock price for SARTORIUS AG?
The current stock price of SRT.DE is 189.2 EUR. The price increased by 4.3% in the last trading session.
What is the dividend status of SARTORIUS AG?
SARTORIUS AG (SRT.DE) has a dividend yield of 0.42%. The yearly dividend amount is currently 0.74.
How is the ChartMill rating for SARTORIUS AG?
SRT.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is SARTORIUS AG (SRT.DE) stock traded?
SRT.DE stock is listed on the Frankfurt Stock Exchange exchange.
What sector and industry does SARTORIUS AG belong to?
SARTORIUS AG (SRT.DE) operates in the Health Care sector and the Life Sciences Tools & Services industry.
What is SARTORIUS AG worth?
SARTORIUS AG (SRT.DE) has a market capitalization of 14.17B EUR. This makes SRT.DE a Large Cap stock.
SRT.DE Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to SRT.DE. When comparing the yearly performance of all stocks, SRT.DE is one of the better performing stocks in the market, outperforming 77.32% of all stocks.
SRT.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SRT.DE. SRT.DE may be in some trouble as it scores bad on both profitability and health.
SRT.DE Financial Highlights
Over the last trailing twelve months SRT.DE reported a non-GAAP Earnings per Share(EPS) of 4.56. The EPS increased by 59.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.8% | ||
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| Debt/Equity | 1.28 |
SRT.DE Forecast & Estimates
8 analysts have analysed SRT.DE and the average price target is 269.28 EUR. This implies a price increase of 42.33% is expected in the next year compared to the current price of 189.2.
For the next year, analysts expect an EPS growth of 22.69% and a revenue growth 5.43% for SRT.DE